Keywords: CHD; Endothelial; PF4; Platelet; Selectins;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ADP; adenosine diphosphate; APC; activated protein C; AT-III; antithrombin III; ATP; adenosine triphosphate; cAMP; cyclic adenosine monophosphate; CLP; cecal ligation - perforation; DIC; disseminated intravascular coagulation; LPS; lipopolysaccharide; IL-
Keywords: critically ill; heparin; heparin-induced thrombocytopenia; thrombocytopenia; thrombosis; APTT; activated partial thromboplastin time; DIC; disseminated intravascular coagulation; DOAC; direct oral anticoagulant; ECMO; extracorporeal membrane oxygenation;
Keywords: early diagnosis of HIT; heparin; HIT; plasma exchange, plasmapheresis; thrombocytopenia; ELISA; enzyme-linked immunosorbent assay; HIT; heparin-induced thrombocytopenia; OD; optical density; PEA; PF4-dependent P-selectin expression assay; PF4; platelet fa
Keywords: 4 T's; The 4 T's score for the estimation of clinical pretest probability; LRÂ +; Â Positive Likelihood Ratio; LRÂ â; Â Negative Likelihood Ratio; HIT; Heparin-Induced Thrombocytopenia; HIPA; Heparin-Induced Platelet Activation assay; HPF4; Heparin-Plat
Keywords: argatroban; danaparoid; fondaparinux; heparin; heparin-induced thrombocytopenia; lepirudin; EIA+/EIAâ; positive/negative platelet factor 4-dependent enzyme immunoassay; HIPA; heparin-induced platelet activation assay; HIPA+/HIPAâ; heparin-induced plat
Keywords: Silk; Fibroin; Silica; Blood compatibility; EPR; enhanced permeability and retention; PEG; poly(ethylene glycol); LPS; lipopolysaccharides; PF4; platelet factor 4;
Keywords: TCN1; transcobalamin I (vitamin B12 binding protein, R binder family); COL4A4; collagen type IV, alpha 4; SAL1; salivary lipocalin; HP; haptoglobin; CILP; cartilage intermediate layer protein, nucleotide pyrophosphohydrolase; IL8; interleukin 8, interleuk
Keywords: ADP; adenosine diphosphate; CAM; cell adhesion molecule; CLEC2; C-type lectin-like receptor-2; COX-2; cyclooxygenase-2; CTCs; circulating tumor cells; G-CSF; granulocyte colony-stimulation factor; Gp; Glycoproteins; GPCRs; G Protein-coupled Receptors; IL-
Keywords: Angiogenesis; Vascular tumor; Cell migration; Taxol; bFGF; PF4
Keywords: Anti-FXa; anti-activated factor X (activity); aPTT; activated partial thromboplastin time; CTAD; citrate, theophylline, adenosine, dipyridamole; CV; coefficient of variation; ELISA; enzyme-linked immunosorbent assay; FV; (coagulation) factor V; INR; inter
Keywords: HIT; Heparin-induced thrombocytopenia; HD; Hemodialysis; PLT; platelet; PF4; platelet factor 4; GAGs; glycosaminoglycans; ULC; ultralarge complexes; LDL; low-density lipoprotein; AVF; arterio-venous fistula; AVG; arterio-venous graft; CVC; central venous
Keywords: heparin; platelet-activating antibodies; thrombocytopenia; thrombosis; ELISA; enzyme-linked immunosorbent assay; HIT; heparin-induced thrombocytopenia; LMWH; low-molecular-weight heparin; OD; optical density; PF4; platelet factor 4; SRA; serotonin-release
Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia
Keywords: 4T; Thrombocytopenia, Timing of platelet count fall, Thrombosis or other sequelae, other causes of Thrombocytopenia; Ab; antibody; ACT; activated clotting time; aPTT; activated partial thromboplastin time; AVR; aortic valve repair; CABG; coronary artery b
The contribution of chronic intermittent hypoxia to OSAHS: From the perspective of serum extracellular microvesicle proteins
Keywords: AUC; area under the curve; CIH; chronic intermittent hypoxia; CRP; C-reactive protein; DEPs; differentially expressed proteins; FN; fibronectin; HP; haptoglobin; OSAHS; obstructive sleep apnea hypopnea syndrome; PF4; placelet factor 4; ROC; receiver opera
The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelinesâ-Anticoagulation During Cardiopulmonary Bypass
Keywords: ACT; activated clotting time; AmSECT; The American Society of Extracorporeal Technology; CPB; cardiopulmonary bypass; ECT; ecarin clotting time; ELISA; enzyme-linked immunosorbent assay; HIPA; heparin-induced platelet activation; HIT; heparin-induced thro
Preclinical performance of a pediatric mechanical circulatory support device: The PediaFlow ventricular assist device
Keywords: CF; continuous-flow; FDA; Food and Drug Administration; LV; left ventricle; MCS; mechanical circulatory support; NIH; normalized index of hemolysis; NHLBI; National Heart Lung and Blood Institute; PF3; third-generation PediaFlow; PF4; fourth-generation Pe
Implementation of a rapid HIT immunoassay at a university hospital - Retrospective analysis of HIT laboratory orders in patients with thrombocytopenia
Keywords: CLIA; chemiluminescent immunoassay; DTI; direct thrombin inhibitor; EDTA; ethylenediaminetetraacetic acid; ELISA; enzyme-linked immunosorbent assay; HIPA; heparin-induced platelet activation; HIT; heparin-induced thrombocytopenia; ICU; intensive care unit
Effect of platelet-derived β-thromboglobulins on coagulation
Keywords: CTAPIII; Connective Tissue Activating Peptide III; ETP; Endogenous thrombin potential; CTAPIII; Neutrophil Activating Peptide III; PBP; Platelet Basic Protein; βTG; Platelet-derived β-thromboglobulin; PF4; Platelet Factor 4; tpeak; Time to peak; TF; Tis
TGF-β1-induced PAI-1 contributes to a profibrotic network in patients with eosinophilic esophagitis
Keywords: Eosinophil; esophagitis; SerpinE1; remodeling; fibrosis; TGF-β1; BZH; Basal zone hyperplasia; EoE; Eosinophilic esophagitis; LP; Lamina propria; LRP1; Lipoprotein receptor-related protein 1; MMP; Matrix metalloproteinases; PAI-1; Plasminogen activator
A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis
Keywords: heparin; thrombocytopenia; thrombosis; 4Ts; thrombocytopenia, timing of platelet count fall, thrombosis, and other causes of thrombocytopenia; AUC; area under the curve; GPIIb; glycoprotein IIb; HDH; high-dose heparin; HIT; heparin-induced thrombocytopeni
Pediatric Heparin-Induced Thrombocytopenia: Prevalence, Thrombotic Risk, and Application of the 4Ts Scoring System
Keywords: ELISA; Enzyme-linked immunosorbent assay; HEP; HIT expert probability; HIT; Heparin-induced thrombocytopenia; HITT; HIT with thrombosis; LMWH; Low molecular weight heparin; OD; Optical density; PF4; Platelet factor 4; SRA; Serotonin release assay; UFH; Un
Infiltration of plasma rich in growth factors enhances in vivo angiogenesis and improves reperfusion and tissue remodeling after severe hind limb ischemia
Keywords: BDNF; brain-derived neurotrophic factor; BMP; bone morphogenetic proteins; CXCR4; chemokine receptor type-4; ECs; endothelial cells; EGF; epidermal growth factor; FGF; fibroblast growth factor; GF; growth factors; HGF; hepatocyte growth factor; hSkMbs; hu
Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT) - findings from the GerHIT multi-centre registry study
Keywords: A; argatroban; aPTT; activated partial thromboplastin time; BMI; body-mass index; CRF; case report forms; CRO; Contract Research Organisation; D; danaparoid; DIC; disseminated intravascular coagulation; DTI; direct thrombin inhibitors; DVT; deep vein thro
Ginkgolide B inhibits platelet release by blocking Syk and p38 MAPK phosphorylation in thrombin-stimulated platelets
Keywords: Ginkgolide B; Platelets; Syk; p38MAPK; PF4; CD40L;
New insights in heparin-induced thrombocytopenia by the use of fluid-phase assays to detect specifically platelet factor 4/heparin complex antibodies and antibody-secreting cells
Keywords: PF4; platelet factor 4; Ab; antibodies; ASC; antibody-secreting cells; ELISA; enzyme-linked immunosorbent assay; ELISPOT; enzyme-linked immunospot assay; HIT; heparin-induced thrombocytopenia; EIA; enzyme-immunoassay; Ig; immunoglobulin; heparin-induced t
Augmented atherogenesis in ApoE-null mice co-exposed to polychlorinated biphenyls and 2,3,7,8-tetrachlorodibenzo-p-dioxin
Keywords: PCBs; TCDD; Atherosclerosis; PF4; MCP-1; RIG-I
Diagnosis and Management of Heparin-Induced Thrombocytopenia
Keywords: Platelet factor 4; PF4; Heparin; PF4/H complexes; HIT;
Rola PF4 (chemokiny CXCL4) w powstawaniu skrzepu
Keywords: PF4; chemokiny; model biologiczny wywoÅywania zakrzepicy; PF4; chemokines; carotid artery thrombosis model;
Fondaparinux - data on efficacy and safety in special situations
Keywords: ACS; acute coronary syndrome; anti-Xa; anti-factor Xa activity; APS; antiphospholipid syndrome; BID; twice a day; BMI; body mass index; DVT; deep vein thrombosis; EMA; European Medicines Agency; FDA; U.S. Food and Drug Administration; FEIBA; factor eight
Contribution of Surface Localization to Platelet Activation by CD154 Antibodies and Introduction of a Novel Approach for Studying Immune Complex Activity
Keywords: ACD; acid-citrate-dextrose; HA-IgG; heat-aggregated IgG; HIT; heparin-induced thrombocytopenia; ICs; immune complexes; mAbs; monoclonal antibodies; PEG; polyethylene glycol; PF4; platelet factor 4; sCD154; soluble CD154; SRA; serotonin release assay; CD15
Combined use of the high heparin step and optical density to optimize diagnostic sensitivity and specificity of an anti-PF4/heparin enzyme-immunoassay
Keywords: Heparin-induced thrombocytopenia; HIT; laboratory testing; heparin; PF4
Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice
Keywords: PF4; platelet factor 4; HUVEC; human umbilical vein endothelial cells; LDL; low density lipoproteins; Acrolein; Atherosclerosis; Endothelial cells; Lipoproteins; Platelets and PF4;
Development of a new magnetic beads-based immunoprecipitation strategy for proteomics analysis
Keywords: BPH; Benign prostatic hyperplasia; CGH; comparative genome hybridization; CID; Collision-induced dissociation; GEO; Gene Expression Omnibus; GO; Gene Ontology; GSEA; Gene Set Enrichment Analysis; IP; Immunoprecipitation; KEGG; Kyoto Encyclopedia of Genes
Thrombocytopenia Exacerbates Cholestasis-Induced Liver Fibrosis in Mice
Keywords: Bcl-2; Apoptosis; Cre; Conditional Knockout; ALP; alkaline phosphatase; α-SMA; α-smooth muscle actin; BDL; bile duct ligation; BrdU; 5-bromo-2-deoxyuridine; ECM; extracellular matrix; HGF; hepatocyte growth factor; HSCs; hepatic stellate cells; MMP; mat
Proteomics for prediction and characterization of response to infliximab in Crohn's disease: A pilot study
Keywords: Proteomics; Serum profiling; Infliximab; Crohn's disease; PF4
A clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopenia
Keywords: HIT; heparin-induced thrombocytopenia; PF4; platelet factor 4; LR; low risk; IR; intermediate risk; HR; high risk; ELISA; enzyme-linked immunosorbent assays; PPV; positive predictive value; NPV; negative predictive value; H/PF4; heparin/PF4; SRA; platelet
Molecular pathways of angiogenesis inhibition
Keywords: Angiogenesis; Angiostatic agent; Signaling; Endostatin; Angiostatin; Tumstatin; PF4; 16K hPRL; Apoptosis; Proliferation; Migration;
RUNX1 suppression induces megakaryocytic differentiation of UT-7/GM cells
Keywords: RUNX1; Megakaryocyte; UT7/GM cells; siRNA; CD41a; PF4; GPIIb
Efectos antitrombóticos y antiinflamatorios de los ácidos grasos omega-3
Keywords: Ácidos grasos omega-3; Plaquetas; Leucocitos; Inflamación; Tromboxano A2; Omega-3 fatty acids; Platelets; Leukocytes; Inflammation; Thromboxane A2; DHA; ácido docosahexanoico; DPA; ácido docosapentanoico; EPA; ácido eicosapentanoico; ICAM-1; molécul
Increase in platelet non-integrin type I collagen receptor in patients with systemic sclerosis
Keywords: SSc; systemic sclerosis; ADP; adenosine diphosphate; ATP; adenosine triphosphate; Pf4; platelet factor 4; TXA; thromboxane A2; PDGF; platelet-derived growth factor; TGF-β; tumor growth factor-β; CI; type I collagen; CIII; type III collagen; PRP; platele
Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support
Keywords: 16; 22; 27; aPTT; activated partial thromboplastin time; CAA; column agglutination assay; EIA; enzyme immunoassay; HGW; Hansestadt Greifswald; HIPA; heparin-induced platelet activation assay; HIPA+&id/ IgG+; heparin-induced platelet activation assay posit
FMRFamide-gated sodium channel and ASIC channels: A new class of ionotropic receptors for FMRFamide and related peptides
Keywords: FaNaC; FMRFamide-activated Na+ channel; HaFaNaC; Helix aspersa FaNaC; HtFaNaC; Helisoma trivolvis FaNaC; LsFaNaC; Lymnaea stagnalis FaNaC; AkFaNaC; Aplysia kurodai FaNaC; ASIC; acid-sensing ion channel; ENaC/DEG; epithelial amiloride-sensitive Na+ channel
Incidence of Heparin-Induced Thrombocytopenia and Therapeutic Strategies in Pediatric Cardiac Surgery
Keywords: 25; BW; body weight; CoA; coarctation; DILV; double inlet left ventricle; DORV; double outlet right ventricle; ECC; extracorporeal circulation; ECT; ecarin clotting time; HIT II; heparin induced thrombocytopenia type II; HPIA; heparin-induced platelet act
Platelet release of β-thromboglobulin and platelet factor 4 and serotonin in plasma samples
Keywords: β-TG; β-thromboglobulin; PF4; platelet factor 4; TPA; 12-O-tetradecanoylphorbol 13-acetate; CTAD; citrate-theophylline-adenosine-dipyridamole; Plasma; Platelet factor 4 (PF4); Serotonin; β-thromboglobulin (β-TG);
Heparin-Induced Skin Lesions and Other Unusual Sequelae of the Heparin-Induced Thrombocytopenia Syndrome
Keywords: anaphylactoid reaction; heparin; IgG; skin lesions; thrombocytopenia; DVT; deep-vein thrombosis; HIT-IgG; heparin-induced thrombocytopenia IgG antibodies; HIT; heparin-induced thrombocytopenia; LMWH; low-molecular-weight heparin; PF4; platelet factor 4; U
Low Brain-Derived Neurotrophic Factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity
Keywords: BDNF; major depression; platelet reactivity; PF4; whole blood; plasma; serum;
Association of Heparin-Dependent Antibodies and Adverse Outcomes in Hemodialysis Patients: A Population-Based Study
Keywords: CI; confidence interval; ELISA; enzyme-linked immunosorbent assay; ERSD; end-stage renal disease; HIPA; heparin-induced platelet aggregation; HIT; heparin-induced thrombocytopenia; OD; optic density; PF4; platelet factor 4;
Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: How much class do we need?
Keywords: EIA; enzyme immunoassay; GTI; Genetic Testing Institute; HIT; heparin-induced thrombocytopenia; LMWH; low molecular weight heparin; OD; optical density; PF4; platelet factor-4; ROC; receiver-operating characteristic; SRA; serotonin-release assay; UFH; unf
Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery
Keywords: CI; confidence interval; ELISA; enzyme-linked immunosorbent assay; HIT; heparin-induced thrombocytopenia; HIT(T); heparin-induced thrombocytopenia and thrombosis; Ig; immunoglobulin; OD; optical density; OR; odds ratio; PF4; platelet factor 4; 18; 25;